Julieta H. Sepulveda Yanez, MSc^1,2*, Edwin Quinten, BSc^1*, Marvyn T. Koning, MD^1*, Janneke A. Eken, MSc^1*, Dietmar Pfeifer, PhD^3*, Ruben A.L. De Groen^1*, Diego Alvarez Saravia, BSc^4*, Andreas Agathangelidis, PhD^5*, Cornelis A.M. van Bergen, PhD^1*, Kostas Stamatopoulos, MD^5,6, Joost S.P. Vermaat, MD, PhD¹, Katja Zirlik, MD⁷, Marcelo Navarrete, MD⁸, Hassan Jumaa, PhD^9* and Hendrik Veelken, MD, PhD ¹

¹Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
²Centro Austral de Tecnología Genómica, University of Magallanes, Punta Arenas, Chile
³Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany
⁴Computer Engineering, Magallanes University, Punta Arenas, Chile
⁵Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
⁶Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
⁷Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
⁸School of Medicine, University of Magallanes, Punta Arenas, Chile
⁹Institute of Immunology, University Medical Center Ulm, Ulm, Germany

Shih-Shih Chen, PhD¹, Xiao-Jie Yan, MD PhD^1*, Martina Cardillo, PhD^1*, Anita Ng^1*, Andrew Shih, PhD^2*, Gonzalo Blanco^1*, Morgan King-Richards, MS^1*, Yu-Ju Chen, MS^1*, Yasmine Kieso, MSCR^1*, Joanna M. Rhodes, MD, MSCE³, Kanti R Rai, MD¹ and Nicholas Chiorazzi, MD¹

¹Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY
²Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute For Medical Research, Manhasset, NY
³Northwell Health Cancer Institute, New Hyde Park, NY

Erin Michelle Parry, MD, PhD^1,2, Romain Guieze, MD, PhD^1,3,4*, Ignaty Leshchiner, PhD^5,6*, Connor Johnson, BA^5*, Eugen Tausch, MD^7*, Sameer A. Parikh, MD⁸, Camilla K Lemvigh, MSc^1,9*, Julien Broséus, MD PhD^10,11*, Sébastien Hergalant^12*, Connor Messer^5*, Filippo Utro, PhD^13*, Chaya Levovitz, MD, PhD^13*, Kahn Rhrissorrakrai, PhD^13*, Liang Li^5*, Shuqiang Li, PhD^5,14*, Geoffrey G Fell^15*, Robert A. Redd, MS^15*, Ziao Lin, BS^5*, Binyamin A. Knisbacher, PhD^5*, Christof Schneider, MD^16*, Stacey M. Fernandes, BS^17*, Julian M. Hess^5*, Laura Z. Rassenti, PhD¹⁸, Thomas J. Kipps, MD, PhD¹⁸, Nitin Jain, MD¹⁹, William G. Wierda, MD, PhD²⁰, Florence Cymbalista, MD PhD^21*, Pierre Feugier, MD, PhD^22*, Neil E. Kay, MD²³, Kenneth J Livak, PhD^1,14*, Brian P Danysh, PhD^5*, Chip Stewart, PhD^24*, Donna S. Neuberg, ScD¹⁵, Matthew S. Davids, MD^1,2, Jennifer R. Brown, MD, PhD^1,2, Laxmi Parida, PhD^13*, Stephan Stilgenbauer, MD¹⁶, Gad Getz, PhD^5,25* and Catherine J. Wu, MD^1,2,5

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Harvard Medical School, Boston, MA
³EA 7453 (CHELTER), Université Clermont Auvergne, Clermont-Ferrand, France
⁴Department of Hematology, CHU Clermont Ferrand, Clermont Ferrand, MA, France
⁵Broad Institute of MIT and Harvard, Cambridge, MA
⁶Department of Medicine, Boston University School of Medicine, Boston, MA
⁷Department of Internal Medicine III, Ulm University, Ulm, Germany
⁸Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
⁹Department of Health Technology, Technical University of Denmark, Lyngby, Denmark
¹⁰Inserm UMRS1256 Nutrition-Genetique et Exposition aux Risques Environnementaux, University de Lorraine, Nancy, France
¹¹CHRU-Nancy, University of Lorraine, Nancy, France
¹²Inserm UMRS1256 Nutrition-Genetique et Exposition aux Risques Environnementaux, University de Lorraine, Nancy, AL, FRA
¹³IBM T.J. Watson Research Center, Yorktown Heights, NY
¹⁴Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
¹⁵Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
¹⁶Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
¹⁷Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
¹⁸Moores Cancer Center, University of California, San Diego, La Jolla, CA
¹⁹Department of Leukemia, MD Anderson Cancer Center, Houston, TX
²⁰The University of Texas M.D. Anderson Cancer Center, Houston, TX
²¹Laboratory of Hematology, APHP, Hôpital Avicenne, Bobigny, France
²²CHRU-Nancy, service d'hématologie biologique, pôle laboratoires, University of Lorraine, Nancy, France
²³Department of Immunology, Mayo Clinic, Rochester, MN
²⁴Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
²⁵Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, MA

Heribert Playa-Albinyana, MSc, BSc^1,2,3*, Fabian Arenas, PhD^4,5*, Romina Royo^6*, Ariadna Giró^4,5*, Irene López^4,5,7*, Monica Lopez-Guerra, PhD^4,5,7*, Sílvia Beà, PhD^2,5,7,8*, Elías Campo, PhD MD^2,3,7,8, Ferran Nadeu, PhD^3,8* and Dolors Colomer, PhD^2,3,4,7*

¹Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
²University of Barcelona, Barcelona, Spain
³Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
⁴Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
⁵Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain
⁶Barcelona Supercomputing Center (BSC), Barcelona, Spain
⁷Hematopathology Section, Pathology Department, Hospital Clinic, Barcelona, Spain
⁸Molecular Pathology of Lymphoid Neoplasms Group, IDIBAPS, Barcelona, Spain

Supriya Chakraborty, PhD^1*, Giulia Felician, PhD^1*, Claudio Martines, MS^1*, Alice Bonato, MS^1*, Ana Colado, PhD^1*, Marija Vujovic, BSci^2*, Aleksandar J. Dimovski, MD, PhD^2* and Dimitar G Efremov, MD, PhD¹

¹Molecular Hematology, International Center for Genetic Engineering and Biotechnology, Trieste, Italy
²Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, Macedonian Acadey of Sciences and Arts, Skopje, Macedonia, The former Yugoslav Republic of

Elisa Ten Hacken, PhD¹, Gabriela Brunsting Hoffmann, BS^2*, Kayla Cruz^3*, Erin Michelle Parry, MD, PhD², Elizabeth Witten^2*, Donna S. Neuberg, ScD⁴, Gordon J Freeman, PhD^5* and Catherine J. Wu, MD^3,6,7,8

¹Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Harvard Medical School, Boston, MA
⁴Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Inc, Boston, MA
⁷Broad Institute of MIT and Harvard, Cambridge, MA
⁸Department of Medicine, Brigham and Women's Hospital, Boston, MA